Pilar Brito‐Zerón

Autoimmune Diseases Induced by TNF-Targeted Therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Sandra Muñoz et al. · Medicine · 2007 · 737 citations

Life Sciences, Immunology, Pharmacotherapy +17

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Stefano Bombardieri et al. · Annals of the Rheumatic Diseases · 2019 · 695 citations · Full text

Medicine, Dermatology, Internal Medicine +16

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Raphaèle Séror, Hendrika Bootsma, Alain Saraux et al. · Annals of the Rheumatic Diseases · 2014 · 313 citations

Medicine, Clinical Sciences, Internal Medicine +17

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

R. Pérez-Álvarez, M. Pérez-de-Lis, Cándido Díaz‐Lagares et al. · Seminars in Arthritis and Rheumatism · 2011 · 300 citations · Full text

Medicine, Immunology, Internal Medicine +12

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Roser Solans et al. · Lara D. Veeken · 2013 · 254 citations · Full text

Medicine, Internal Medicine, Neurology +17